Mining firms including BHP Billiton & Rio Tinto in innovative project to fund clinical trial of HIV/AIDS drug in So. Africa
All components of this story
Author: Kimina Lyall, The Australian
Melbourne-based biotech Virax is...funding a clinical trial of its HIV drug entirely from...donations [by] a consortium of mining companies, led by BHP Billiton and including Rio Tinto and three Japanese companies... Virax CEO David Beames said...the South African trial would make it quicker for AIDS sufferers in the region to gain access to the drug...He said it was an innovative way of raising funding for a trial...”that otherwise depends on the largesse of big pharma companies.”
Author: Madelene Pearson, Bloomberg
...Virax Holdings...said seven global mining companies joined a group led by BHP Billiton...to fund the first emerging-country trials of its HIV/AIDS therapeutic vaccine. The trials will take place in South Africa... BHP is leading participants including Gold Fields Ltd., Harmony Gold Mining Co., Lonmin Plc, Mitsubishi Materials Corp. [part of Mitsubishi], Nippon Mining and Metals Co. [part of Nippon Mining], Sumitomo Metal Mining Co. [part of Sumitomo Group] and Rio Tinto Ltd.
- Related stories: Mining firms including BHP Billiton & Rio Tinto in innovative project to fund clinical trial of HIV/AIDS drug in So. Africa
- Related companies: BHP Billiton Gold Fields Harmony Gold Lonmin Mitsubishi Group Mitsubishi Materials (part of Mitsubishi Group) Nippon Mining Nippon Mining & Metals (part of Nippon Mining) Rio Tinto Sumitomo Group Sumitomo Metal Mining (part of Sumitomo Group) Virax Holdings